Accessibility Statement
SolPeptide by SolXGenix.com is built to be usable by every visitor, including researchers, laboratory buyers, and members of the public who use assistive technology.
Effective Date: August 29, 2026 | Last Updated: August 29, 2026
1. Purpose of This Statement
This Accessibility Statement (“Statement”) describes the steps SolPeptide by SolXGenix.com, owned and operated by Unioncore Trade LLC, has taken and continues to take to make https://solxgenix.com usable by the widest possible range of visitors, including people with visual, auditory, motor, cognitive, or neurological disabilities. It applies to every page of our site, including our product catalog, our Certificate of Analysis (COA) library, our US-Sourced page, our account and checkout system, and our About Us and Contact Us pages.
This Statement is written specifically for our website and reflects the actual accessibility practices in place as of the effective date above. It is not a generic or copy-pasted template. It should be read together with our Privacy Policy and Terms of Service.
2. Business Identification
Business Name: SolPeptide by SolXGenix.com
Registered Company Name: Unioncore Trade LLC
EIN: 41-2920005
Business Address: 5830 E 2nd St, Ste 7000 #31050, Casper, WY 82609, United States
Email: info@solpeptide.com
Phone: 1-404-770-5020
Support Hours: Mon–Fri, 9:00 AM – 6:00 PM EST. We aim to respond to all enquiries within 1 business day.
Website: https://solxgenix.com
Products: Research-grade peptides (Research Use Only / RUO) sold via our catalog at /shop
Service Area: We currently ship to addresses within the United States of America only.
3. Accessibility Standard We Measure Against
We use the Web Content Accessibility Guidelines (WCAG) 2.1, Level AA, published by the World Wide Web Consortium (W3C), as the technical benchmark for our accessibility work, and we monitor WCAG 2.2 as the guidelines our team is progressively adopting. WCAG is the standard referenced by U.S. courts and the U.S. Department of Justice when assessing whether a commercial website is accessible under the Americans with Disabilities Act (ADA), so we treat it as our working benchmark even though no single technical standard has yet been formally adopted into federal ADA regulations for private businesses.
4. Measures We Have Taken
SolPeptide by SolXGenix.com takes the following measures to support accessibility across our website:
- Semantic structure: pages use proper heading levels, landmarks, and list structures so that screen readers can present the page in a logical order.
- Text alternatives: product photos, icons, and informational images include descriptive alternative (“alt”) text so their meaning is available to visitors who cannot see them.
- Keyboard accessibility: core site functions — browsing the catalog, opening a product page, adding an item to cart, and completing checkout — are designed to be operable using a keyboard alone, without requiring a mouse or touch input.
- Visible focus indicators: interactive elements such as links, buttons, and form fields display a visible outline when navigated to by keyboard, so users always know where they are on the page.
- Color contrast: body text, headings, and buttons are designed to meet WCAG AA contrast ratios against their background so that text remains legible for visitors with low vision or color-vision deficiencies.
- Resizable text and responsive layout: our site is built with a responsive layout that reflows for different screen sizes and supports browser zoom and text-resizing up to 200% without loss of content or function.
- Labeled forms: our account login, checkout, and contact-us forms use associated labels and clear error messages so that screen-reader users and users with cognitive disabilities can understand what information is required.
- No seizure-inducing content: our site does not use flashing or strobing animation effects that could trigger photosensitive seizures.
- Descriptive links: navigation links and buttons are written to describe their destination or function rather than relying on ambiguous text such as “click here.”
5. Compatibility with Assistive Technology
We aim for https://solxgenix.com to be compatible with commonly used assistive technologies, including:
- Screen readers, including JAWS, NVDA, VoiceOver (macOS/iOS), and TalkBack (Android).
- Screen magnification software and operating-system zoom features.
- Speech-recognition and voice-navigation software, such as Dragon NaturallySpeaking.
- Keyboard-only navigation, switch devices, and alternative pointing devices.
- Current versions of major browsers, including Google Chrome, Mozilla Firefox, Apple Safari, and Microsoft Edge, on both desktop and mobile devices.
Because assistive technology and browsers update frequently, occasional compatibility issues can occur even on a well-maintained site. If you experience a problem using any assistive technology on our site, please contact us using the details in Section 9 and we will work with you to resolve it.
6. Accessibility Features Specific to Our Store
6.1 Product Catalog and Certificates of Analysis: Our product catalog is organized with consistent headings, filterable categories, and descriptive product titles. Certificates of Analysis in our COA library are provided as downloadable documents; where a certificate is an image-based scan rather than searchable text, we are working to provide a text-based summary or alternative format on request (see Section 9).
6.2 Account, Cart, and Checkout: Creating an account, adding research peptides to your cart, and completing checkout are each built with labeled form fields, clear error and confirmation messages, and a logical tab order so that these steps can be completed using a keyboard or screen reader.
6.3 Contact and Support Channels: If any part of our website is difficult for you to use, you are never limited to the website alone. Our Contact Us page, our support email (info@solpeptide.com), and our support phone line (1-404-770-5020) are available as accessible alternative channels to browse our catalog, ask questions, or place an order, Monday – Friday, 9:00 AM – 6:00 PM Eastern Time.
7. Known Limitations and Ongoing Work
Despite our efforts, no website can guarantee full accessibility for every user, every assistive technology, and every browser combination at all times. We are aware that some areas of our site may not yet fully meet WCAG 2.1 AA, including, potentially:
- Legacy Certificate of Analysis (COA) files or research documents that predate our current accessibility process and may not yet be fully tagged for screen readers.
- Embedded third-party tools, such as our payment processor, live chat widget, or shipment-tracking interface, which are built and maintained outside our direct control and may have their own accessibility limitations.
- Occasional third-party marketing or blog content, such as embedded video, that may not yet include captions or transcripts.
We treat these as active items on our roadmap, not as accepted limitations. If you encounter any barrier not listed here, please tell us — your report directly shapes what we fix next.
8. Third-Party Content and Links
Our site links to third-party resources, including our payment gateway, our affiliate Affiliate Policy, and social media pages. We do not control the accessibility of websites operated by third parties, and this Statement does not extend to those external sites. We select reputable third-party vendors and encourage them to meet recognized accessibility standards, but responsibility for their content rests with those third parties.
9. Feedback and Requesting Assistance
We want to know about any accessibility barrier you encounter on our site, no matter how small. When you contact us, please include, if possible: the web page (URL) involved, the assistive technology and browser you were using, and a description of the difficulty you experienced. This helps us diagnose and fix the issue as quickly as possible.
Email: info@solpeptide.com
Phone: 1-404-770-5020
Contact Form: /contact
Mail: 5830 E 2nd St, Ste 7000 #31050, Casper, WY 82609, United States
Support Hours: Mon–Fri, 9:00 AM – 6:00 PM EST
We aim to acknowledge accessibility feedback within 1 business day and to provide a substantive response, including next steps or a timeline for resolution, as promptly as possible thereafter. If you need information from our site in an alternative format, or need help completing an order because of an accessibility barrier, our support team can assist you directly by phone or email.
10. Federal Legal Framework
10.1 Americans with Disabilities Act (ADA) — 42 U.S.C. § 12181 et seq.: Title III of the ADA prohibits discrimination on the basis of disability by places of public accommodation. While the ADA does not name a specific technical standard for websites, U.S. Department of Justice guidance confirms that the ADA's nondiscrimination requirements apply to the goods and services a business offers through its website, and federal courts commonly reference WCAG when evaluating whether a website is accessible. We align our practices with this guidance.
10.2 Rehabilitation Act of 1973 — 29 U.S.C. § 794 (Section 504) and 29 U.S.C. § 794d (Section 508): Sections 504 and 508 of the Rehabilitation Act require accessibility for entities that receive federal funding or for federal agencies and their contractors. SolPeptide by SolXGenix.com is a private commercial business that does not receive federal funding and is not a federal contractor, so these sections do not directly apply to us; however, we voluntarily use the WCAG-based standards referenced in Section 508 as a best-practice benchmark.
10.3 Federal Trade Commission Act — 15 U.S.C. § 41 et seq.: The FTC Act prohibits unfair or deceptive practices in commerce, including inaccurate statements about a company's accessibility efforts. This Statement is written to accurately describe our current practices and limitations so that no visitor is misled about the accessibility of our site.
11. State-Specific Accessibility and Anti-Discrimination Laws
In addition to the federal ADA, a number of states have their own civil-rights and anti-discrimination statutes that have been applied by courts to commercial websites, sometimes with their own enforcement mechanisms and remedies. This information is provided for transparency and general reference only and is not legal advice. Because case law in this area develops quickly, residents should confirm current requirements independently.
| State | Law | Relevance to Website Accessibility |
|---|---|---|
| California | Unruh Civil Rights Act, Cal. Civ. Code § 51; California ADA-alignment case law | California courts have held that a violation of the ADA can also constitute a violation of the Unruh Act, which provides for statutory minimum damages; California has significant website-accessibility litigation activity. |
| New York | New York State Human Rights Law (NYSHRL), N.Y. Exec. Law § 290 et seq.; New York City Human Rights Law (NYCHRL), N.Y.C. Admin. Code § 8-101 et seq. | Both laws have been applied by courts to commercial websites as places of “public accommodation,” in addition to ADA claims. |
| Florida | Florida Civil Rights Act, Fla. Stat. § 760.01 et seq. | State-level nondiscrimination protections that have been raised alongside ADA website-accessibility claims in Florida federal courts. |
| Texas | Texas Human Resources Code § 121.001 et seq. (Texas Architectural Barriers Act framework and related nondiscrimination provisions) | State nondiscrimination protections for persons with disabilities that operate alongside federal ADA obligations. |
| Pennsylvania | Pennsylvania Human Relations Act, 43 P.S. § 951 et seq. | State nondiscrimination law applied to places of public accommodation, including online storefronts, in some federal court decisions. |
| New Jersey | New Jersey Law Against Discrimination, N.J.S.A. § 10:5-1 et seq. | State civil-rights statute under which website-accessibility claims against commercial businesses have been brought. |
| Illinois | Illinois Human Rights Act, 775 ILCS 5/1-101 et seq. | State nondiscrimination protections that complement ADA obligations for online places of public accommodation. |
| Massachusetts | Massachusetts Public Accommodation Law, M.G.L. c. 272, § 98 | State law prohibiting discrimination in places of public accommodation, referenced in some website-accessibility disputes. |
| All other states | Federal ADA and FTC Act (default framework) | Residents of states without a distinct website-accessibility statute are protected primarily by the federal ADA's public-accommodation provisions and the FTC Act's prohibition on deceptive practices; we apply the same accessibility practices and feedback process described in this Statement to every visitor, regardless of state. |
Important Note on the State Table: State accessibility and anti-discrimination law is an active and fast-changing area of U.S. law. The information above reflects our understanding as of August 29, 2026, and is provided for general reference only — not legal advice. Regardless of which state you are visiting from, we apply the same accessibility practices, the same feedback process, and the same commitment to remediation for every U.S. visitor to our site.
12. International and General Consumer-Rights Principles
Consistent with broader international consumer-rights and accessibility standards — including the principles reflected in the UK Equality Act 2010 and the EU Web Accessibility Directive, even though our sales are governed by U.S. law and we currently ship only within the United States — we commit to:
- Equal access: providing the same information and purchasing opportunities to visitors with disabilities as to any other visitor.
- Transparency: honestly describing both what we have achieved and what we still have to improve, rather than making unqualified accessibility claims.
- Responsive remediation: investigating and addressing accessibility reports raised through the channels in Section 9 in a timely manner.
- Non-retaliation: never penalizing a customer for raising an accessibility concern or requesting an accommodation.
13. Continuous Improvement
Accessibility is not a one-time project for us; it is an ongoing commitment. We periodically review our website against WCAG 2.1 AA (and, progressively, WCAG 2.2), retest key user flows such as browsing the catalog and completing checkout, and update this Statement when we make meaningful changes to our accessibility practices. This Statement will be updated with a new “Last Updated” date whenever such changes are made.
15. Disclaimer
⚠ DISCLAIMER: This Accessibility Statement describes the good-faith efforts of SolPeptide by SolXGenix.com, operated by Unioncore Trade LLC (EIN: 41-2920005), to make https://solxgenix.com accessible. This Statement is not a warranty or guarantee of full, uninterrupted, or error-free accessibility, and it is not legal advice. All products sold on this website are sold strictly for in vitro laboratory research use only (RUO), are not FDA-approved, and are not intended to diagnose, treat, cure, or prevent any disease. SolPeptide by SolXGenix.com is not a compounding pharmacy or outsourcing facility as defined under Sections 503A/503B of the Federal Food, Drug, and Cosmetic Act.